Over the last four years, Canada has had a grand total of 16 "flu-associated" fatalities for their pediatric age category -- which includes everybody under the age of 18.
This included all H1N1 and seasonal cases. Three-quarters of these deaths had severe and chronic underlying health conditions.
That's 16 total deaths among a pediatric population of 7.86 million, the majority of whom -- 60 percent or more -- remained unvaccinated.
By comparison, during the same four-year time span, the identical U.S. pediatric group had 553 flu-associated deaths. Compared on a per capita basis, the U.S. exhibits a stunning 3.2 times death rate over Canada.
According to Age of Autism:
"Canada's pediatric group averaging a single flu-associated death per year the last four years strongly questions the sanity of promoting a mercury-laden flu vaccine jab that also brings many other toxic ingredients such as aluminum-compound adjuvants and many other alien substances into cellular contact of fragile developing neurological systems, particularly infants and kids as young as six months."
New research is also adding to evidence that vitamin D may help reduce the spread of viral respiratory tract infections, including influenza.
A new study followed close to 200 adults during fall and winter. Participants had blood samples drawn monthly, and a 25-hydroxyvitamin D test was used to measure vitamin D levels. All participants were asked to report any evidence of an acute respiratory tract infection -- such as nasal congestion, sore throat, cough, fever, chills, fatigue or general malaise.
According to Newswise:
"Of the 18 participants who maintained vitamin D levels of 38 ng/ml or higher during the study period, only three (16.6 percent) developed viral infections. Of the 180 other participants, 81 (45 percent) developed viral infections. Those with the higher vitamin D levels also experienced a marked reduction in the number of days ill."